A CASE OF SECONDARY ATROPHIC RHINITIS WITH HANSEN’S DISEASE
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 19
Abstract
PRESENTATION OF THE CASE Atrophic rhinitis is an uncommon disorder in modern societies and its incidence varies from 0.3-7.8% of the population. 1 It can be classified as primary atrophic rhinitis which arises de novo or secondary atrophic rhinitis which may occur as a sequela of granulomatous diseases such as leprosy, syphilis, etc., comprises only 1% of the cases.2 Thus such cases are of clinical importance and rarity. Atrophic rhinitis (AR) is a debilitating chronic nasal mucosal disease of unknown aetiology. The condition is characterized by progressive nasal mucosal atrophy, progressive atrophy of the underlying bone of the turbinates, abnormal widening (roomy) / patency of the nasal cavities (with paradoxical congestion) and viscid secretions and dried crusts leading to a characteristic fetor (ozaena).3,4,5 On the basis of causes AR can be classified as; Primary Atrophic rhinitis which has decreased markedly in incidence (0.3-1%) and the aetiology is unknown2,3,6 and secondary atrophic rhinitis is mostly common in developed countries. The most common cause is sinus surgery, it alone comprises of 90% of secondary atrophic rhinitis, common procedures include partial and total turbinectomy (80%), without turbinectomy (10%) and partial maxillectomy (10%), followed by radiation (2.5%), trauma (1%) and granulomatous or infectious diseases (1%).2,7 The malady of “empty nose syndrome is associated with extensive turbinate surgeries causing secondary Atrophic Rhinitis”.8 Little is known about this secondary form and it remains incompletely characterized. It has occurred in association with chronic granulomatous diseases of the nose including leprosy, sarcoidosis, rhinoscleroma, Wegener’s granulomatosis and infectious diseases like TB and syphilis. The onset after treatment with antiangiogenic drug underlines the role of the microvasculature in the pathogenesis.2,9 While these causes were once common, now only comprise of 1-2% cases, thus rare.2 Secondary atrophic rhinitis is typically seen in older population.
Authors and Affiliations
Nowsheen Hamdani, Vijaya Kumar M
Keywords
Related Articles
- EP ID EP557441
- DOI 10.18410/jebmh/2018/334
- Views 111
- Downloads 0
EFFICACY OF DIRECTLY ACTING ANTIVIRAL DRUGS FOR HCV IN REAL LIFE: EXPERIENCE FROM A TERTIARY CARE CENTRE OF NORTH INDIA
BACKGROUND Since its discovery, treatment of hepatitis C virus (HCV) has undergone extensive changes. Antiviral treatments and sustained virological responses (SVR) have also improved from the early interferon monotherap...
COMPARATIVE STUDY OF COMPLICATIONS IN ENDOSCOPIC SEPTOPLASTY VERSUS CONVENTIONAL SEPTOPLASTY
BACKGROUND The objectives of the study are- 1) To study the gender distribution of Deviated Nasal Septum (DNS). 2) To study the incidence of DNS in different age groups. 3) To compare the complications of septoplasty in...
Head of the Department, Department of General Medicine, GITAM Institute of Medical Sciences and Research, Visakhapatnam, Andhra Pradesh
BACKGROUND Parkinson’s disease (PD) is the second most common neurodegenerative disorder. It is a result of degeneration of the substantia nigra, pars compacta with dysfunction of dopaminergic nigrostriatal pathway. The...
LEARNING STYLE PREFERENCES OF FIRST YEAR UNDERGRADUATE MEDICAL STUDENTS
Students have different preferences in the way they receive and process information. The VARK learning style model classifies students into four different learning modes; visual (V), aural (A), read/write (R), and kinest...
SCLEROTHERAPY FOR MALIGNANT PLEURAL EFFUSIONS- A PROSPECTIVE RANDOMIZED TRIAL OF VINCRISTINE VERSUS CISPLATIN
BACKGROUND Malignant pleural effusions are a common cause of morbidity in patients with advanced cancer. Cancer of the lung breast and lymphomas account for approximately 75 % of malignant pleural effusions. Sarcomas and...